It is a GLP-1 receptor agonist used to improve glycemic control in Type-II diabetes mellitus
Altogether, these results indicate that pharmacological inhibition of MAOB with KDS2010 effectively mitigates PTSD-associated deficits by reducing aberrant astrocytic GABA, restoring behavioral functions, and supporting the therapeutic potential of MAOB inhibitors in PTSD treatment
Tirzepatide arrived more recently, with Mounjaro approved for diabetes in November 2022 and Zepbound receiving weight management approval in May 2025
DIGESTIVE SUPPORT for GLP-1 USERS: Enteric-coated peppermint oil capsules may offer some support for the common gut-related side effects such as occassional bloating, cramping and gas
Diet and Exercise for Better Sleep What you eat and how you move during the day can significantly impact your sleep at night
Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration
